Propel mometasone furoate implant - PDFSEARCH.IO - Document Search Engine

Propel mometasone furoate implant
Results: 22

#	Item
1	PROPEL® mini (mometasone furoate implant, 370 µg) Instructions For Use CAREFULLY READ ALL INSTRUCTIONS PRIOR TO USE STERILE: STORAGE: Add to Reading List Source URL: propelopens.com - Date: 2016-06-09 16:50:32
2	PROPEL® (mometasone furoate implant, 370 µg) Instructions For Use CAREFULLY READ ALL INSTRUCTIONS PRIOR TO USE STERILE: STORAGE: Add to Reading List Source URL: propelopens.com Language: English - Date: 2016-04-01 12:43:40 Medicine Medical technology Medical equipment Propel mometasone furoate implant Sinus implant Prosthetics Sinusitis Intersect ENT Implant Breast implant
3	Intersect ENT Announces Publication of PROGRESS Study of Steroid Releasing Implant in Patients With Frontal Sinus Disease Results Demonstrate Clinical Benefits of PROPEL mini in Difficult-to-Treat Patient Population MENL Add to Reading List Source URL: propelopens.com Language: English - Date: 2016-07-08 12:30:12 Medicine Medical equipment Medical technology Propel mometasone furoate implant Sinus implant Intersect ENT Sinusitis Otorhinolaryngology Sinus Balloon sinuplasty
4	Intersect ENT Announces Completion of Enrollment in RESOLVE II Clinical Trial of New In-Office Implant for Recurrent Chronic Sinusitis Company Also Announces Publication of Positive Six-Month Results from RESOLVE Clinica Add to Reading List Source URL: propelopens.com Language: English - Date: 2016-06-01 10:43:20 Medicine Medical technology Medical equipment Propel mometasone furoate implant Intersect ENT RTT Sinusitis Otorhinolaryngology Sinus Mometasone furoate Sinus implant
5	Intersect ENT Recognized for Gender Diversity by Watermark and UC Davis Company Also Recognized in Deloitte’s 2015 Technology Fast 500 MENLO PARK, Calif., November 17, 2015 – Intersect ENT, Inc. (Nasdaq:XENT), a comp Add to Reading List Source URL: propelopens.com Language: English - Date: 2015-11-17 11:28:47 Medicine Intersect ENT Propel mometasone furoate implant Otorhinolaryngology Sinusitis Sinus
6	Intersect ENT Announces Data Further Demonstrating Health Economic Value of PROPEL Steroid Releasing Implants Savings Associated with Reduced Post-Operative Interventions Support Use of PROPEL MENLO PARK, Calif., Novembe Add to Reading List Source URL: propelopens.com Language: English - Date: 2015-11-10 10:16:52 Medicine Medical equipment Medical technology Propel mometasone furoate implant Intersect ENT Sinusitis Sinus Otorhinolaryngology Sinus implant
7	Intersect ENT Announces Publication of Position Statement from AAO-HNS on Use of Biomaterials Statement Supports Use of PROPEL, the Only FDA-Approved Biomaterial Used to Improve Patient Outcomes in Sinus Procedures Menlo Add to Reading List Source URL: propelopens.com Language: English - Date: 2015-10-21 16:28:17 Medicine Medical equipment Medical technology Propel mometasone furoate implant RTT Intersect ENT Sinusitis Surgical specialties Sinus Otorhinolaryngology Endoscopy Sinus implant
8	Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany Decision Represents Early Step in Building the Company’s Foundation Internationally MENLO PARK, Calif.—January 29, 2016—Intersect Add to Reading List Source URL: propelopens.com Language: English - Date: 2016-02-02 07:14:47 Medicine Intersect ENT Propel mometasone furoate implant Sinus implant Forward-looking statement Sinusitis Otorhinolaryngology Sinus Mometasone furoate
9	Intersect ENT Announces FDA Approval of Additional Indication for PROPEL® Mini Sinus Implant PROPEL Mini Now Indicated to Treat Patients With Frontal Sinus Disease MENLO PARK, Calif.—March 23, 2016—Intersect ENT, In Add to Reading List Source URL: propelopens.com Language: English - Date: 2016-03-23 16:11:00 Medical equipment Medical technology Propel mometasone furoate implant RTT Sinus implant Sinusitis Intersect ENT Sinus Otorhinolaryngology Paranasal sinuses Frontal sinus Balloon sinuplasty
10	Intersect ENT Appoints David Lehman General Counsel MENLO PARK, Calif., February 22, 2016 – Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat Add to Reading List Source URL: propelopens.com Language: English Intersect ENT Propel mometasone furoate implant Forward-looking statement Otorhinolaryngology Sinusitis Thoratec

UPDATE